Climb Bio, Inc.
CLYM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001768446
In the last 90 days, Climb Bio, Inc. insiders filed 0 open-market purchases and 2 sales; 108 institutions reported holding it in 13F filings for Q2 2026, worth $734.3M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Climb Bio, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +26 vs. Q1 2024
- Shares held
- 49.9M
- +33.1M (+196.1%) vs. Q1 2024
- Total value
- $354.8M
- +$308.6M (+668.1%) vs. Q1 2024
- New holders
- 31
- 10 more added
- Sold out
- 5
- 4 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLYM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 108 | $734.3M |
| Q1 2026 | 80 | $221.2M |
| Q4 2025 | 65 | $157.4M |
| Q3 2025 | 68 | $89.7M |
| Q2 2025 | 69 | $61.9M |
| Q1 2025 | 76 | $63.4M |
| Q4 2024 | 80 | $100.3M |
| Q3 2024 | 71 | $278.2M |
| Q2 2024 | 47 | $354.8M |
| Q1 2024 | 21 | $46.2M |
| Q4 2023 | 23 | $45.5M |
| Q3 2023 | 23 | $44.0M |
| Q2 2023 | 22 | $46.8M |
| Q1 2023 | 19 | $48.4M |
| Q4 2022 | 20 | $61.0M |
| Q3 2022 | 22 | $47.8M |
| Q2 2022 | 29 | $45.7M |
| Q1 2022 | 43 | $146.8M |
| Q4 2021 | 35 | $181.8M |
| Q3 2021 | 32 | $310.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Climb Bio, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 31,419,267 | $223.4M | 2.95% | +18,268,418+138.9% | Added |
| Deep Track Capital, LP | 3,904,785 | $27.8M | 0.83% | +3,904,785 | New |
| Samsara BioCapital, LLC | 3,261,393 | $23.2M | 4.85% | +3,261,393 | New |
| Janus Henderson Group PLC | 3,253,988 | $23.1M | 0.01% | +3,253,988 | New |
| Boxer Capital, LLC | 2,603,190 | $18.5M | 0.97% | +2,603,190 | New |
| Affinity Asset Advisors, LLC | 1,670,661 | $11.9M | 1.87% | +1,670,661 | New |
| Driehaus Capital Management LLC | 696,057 | $4.95M | 0.05% | −115,623−14.2% | Reduced |
| Adage Capital Partners GP, L.L.C. | 670,362 | $4.77M | 0.01% | +670,362 | New |
| Ally Bridge Group (NY) LLC | 500,000 | $3.56M | 2.12% | +500,000 | New |
| BlackRock Inc. | 381,723 | $2.71M | 0.00% | +351,283+1,154.0% | Added |
| Vanguard Group Inc | 326,381 | $2.32M | 0.00% | +15,895+5.1% | Added |
| Sphera Funds Management Ltd. | 215,179 | $1.53M | 0.25% | +215,179 | New |
| Walleye Capital LLC | 196,390 | $1.40M | 0.01% | +196,390 | New |
| Geode Capital Management, LLC | 171,597 | $1.22M | 0.00% | +104,971+157.6% | Added |
| Ikarian Capital, LLC | 100,000 | $711.0K | 0.22% | +100,000 | New |
| ADAR1 Capital Management, LLC | 97,695 | $694.6K | 0.14% | +97,695 | New |
| State Street Corp | 59,007 | $419.5K | 0.00% | +37,307+171.9% | Added |
| Bridgeway Capital Management, LLC | 55,223 | $392.6K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 45,677 | $324.8K | 0.00% | +2,209+5.1% | Added |
| Renaissance Technologies LLC | 37,000 | $263.1K | 0.00% | +26,383+248.5% | Added |
| Man Group plc | 33,567 | $238.7K | 0.00% | +33,567 | New |
| Boothbay Fund Management, LLC | 30,710 | $218.3K | 0.01% | +30,710 | New |
| Woodline Partners LP | 22,192 | $157.8K | 0.00% | +22,192 | New |
| Bank of New York Mellon Corp | 18,845 | $134.0K | 0.00% | +18,845 | New |
| Charles Schwab Investment Management Inc | 17,128 | $121.8K | 0.00% | +17,128 | New |
| New York State Common Retirement Fund | 13,300 | $94.6K | 0.00% | +13,300 | New |
| Dimensional Fund Advisors LP | 12,560 | $89.3K | 0.00% | +12,560 | New |
| Millennium Management LLC | 11,397 | $81.0K | 0.00% | −8,709−43.3% | Reduced |
| Polar Asset Management Partners Inc. | 10,781 | $76.7K | 0.00% | +10,781 | New |
| Two Sigma Securities, LLC | 10,619 | $75.5K | 0.00% | +10,619 | New |
| Morgan Stanley | 9,883 | $70.3K | 0.00% | +8,174+478.3% | Added |
| Bank of America Corp | 9,247 | $65.7K | 0.00% | +9,247 | New |
| Rhumbline Advisers | 8,233 | $58.5K | 0.00% | +8,233 | New |
| STRS Ohio | 5,300 | $37.7K | 0.00% | +5,300 | New |
| Corebridge Financial, Inc. | 3,918 | $27.9K | 0.00% | +3,918 | New |
| Wells Fargo & Company | 3,149 | $22.4K | 0.00% | +3,099+6,198.0% | Added |
| JPMorgan Chase & Co | 3,104 | $22.1K | 0.00% | +3,104 | New |
| Advisor Group Holdings, Inc. | 8,333 | $21.7K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,020 | $21.5K | 0.00% | −586−16.3% | Reduced |
| Barclays PLC | 2,543 | $18.1K | 0.00% | +2,543 | New |
| UBS Group AG | 2,218 | $15.8K | 0.00% | −3,707−62.6% | Reduced |
| Citigroup Inc | 1,632 | $11.6K | 0.00% | +1,632 | New |
| Ameritas Investment Partners, Inc. | 714 | $5.08K | 0.00% | +714 | New |
| Royal Bank of Canada | 686 | $5.00K | 0.00% | +623+988.9% | Added |
| Legal & General Group Plc | 631 | $4.52K | 0.00% | +631 | New |
| California State Teachers Retirement System | 528 | $3.75K | 0.00% | +528 | New |
| Amalgamated Bank | 252 | $2.00K | 0.00% | +252 | New |
| BML Capital Management, LLC | 0 | $0 | 0.00% | −2,193,742−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −78,276−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −29,466−100.0% | Sold out |
| Chicago Partners Investment Group LLC | 0 | $0 | 0.00% | −12,104−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −981−100.0% | Sold out |